Corvus Pharmaceuticals, Inc. (CRVS) Share-based Payment Arrangement, Expense USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Corvus Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2024.
  • Corvus Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $689 K, a 40% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $2.34 M, a 4.13% decline year-over-year.
  • Corvus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.15 M, a 20.2% decline from 2022.
  • Corvus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.69 M, a 36.4% decline from 2021.
  • Corvus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.23 M, a 26.4% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.34 M $689 K +$197 K +40% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $2.15 M $572 K -$48 K -7.74% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $2.2 M $546 K -$112 K -17% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $2.31 M $537 K -$138 K -20.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $2.45 M $492 K -$247 K -33.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $2.69 M $620 K -$118 K -16% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $2.81 M $658 K -$438 K -40% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $3.25 M $675 K -$498 K -42.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $3.75 M $739 K -$486 K -39.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $4.23 M $738 K -$498 K -40.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-19
Q3 2021 $4.73 M $1.1 M -$187 K -14.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $4.92 M $1.17 M -$210 K -15.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $5.13 M $1.23 M -$620 K -33.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $5.75 M $1.24 M -$512 K -29.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-28
Q3 2020 $6.26 M $1.28 M -$466 K -26.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 $6.73 M $1.38 M -$515 K -27.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $7.24 M $1.85 M -$108 K -5.53% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $7.35 M $1.75 M -$56 K -3.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 $7.4 M $1.75 M -$45 K -2.51% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $7.45 M $1.9 M +$162 K +9.33% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 $7.29 M $1.95 M +$152 K +8.44% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $7.14 M $1.8 M +$65 K +3.74% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-25
Q3 2018 $7.07 M $1.79 M +$293 K +19.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $6.78 M $1.74 M +$215 K +14.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $6.56 M $1.8 M +$333 K +22.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $6.23 M $1.74 M +$691 K +65.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-09
Q3 2017 $5.54 M $1.5 M +$237 K +18.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $5.3 M $1.52 M +$446 K +41.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $4.86 M $1.47 M +$1.03 M +233% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 $3.83 M $1.05 M +$762 K +266% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 $3.07 M $1.26 M +$1.14 M +928% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $1.93 M $1.08 M +$1.06 M +6224% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $867 K $441 K +$439 K +21950% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $428 K $286 K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $123 K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $17 K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $2 K* Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.